Navigation Links
VIDA Diagnostics Earns ISO 13485 and CE Certifications
Date:9/19/2011

CORALVILLE, Iowa, Sept. 19, 2011 /PRNewswire/ -- VIDA Diagnostics, a leading developer of quantitative pulmonary imaging software, announced today that the company has achieved International Organization for Standardization (ISO 13485) certification and CE certification for its flagship product, Apollo®. The CE certification permits VIDA to sell Apollo for clinical use in the European Economic Area (EEA) and Switzerland. Apollo currently has FDA 510(k) approval for clinical use in the U.S.

Apollo is VIDA's recently released, pulmonary image analysis solution designed to assess pulmonary disease objectively and repeatedly with unprecedented speed and accuracy.  Used for the early detection, evaluation and aiding of treatment of pulmonary disease including COPD, emphysema, lung cancer, and asthma; VIDA's analysis methodology has been successfully tested in multiple academic and clinical trials.

"Receiving these certifications are significant milestones for VIDA Diagnostics in establishing high quality standards and generating a solid platform for commercialization in the worldwide market," stated Susan A. Wood, Ph.D., VIDA Diagnostics' President and Chief Executive Officer.  "We are excited to expand the reach of VIDA solutions."

VIDA Diagnostics will be attending the European Respiratory Society 2011 Congress in Amsterdam, Netherlands, September 25-28, 2011.

About VIDA Diagnostics

VIDA Diagnostics is a leader in clinically-validated quantitative pulmonary analysis software for the early detection, evaluation and treatment of pulmonary disease including COPD, emphysema, lung cancer, and asthma. FDA approved and CE certified, VIDA's analysis methodology has been successfully tested in multiple academic, pulmonary device, and pharmaceutical clinical trials.

www.vidadiagnostics.com


'/>"/>
SOURCE VIDA Diagnostics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Quest Diagnostics to Speak at the Morgan Stanley Global Healthcare Conference
2. Dominion Diagnostics Leads Fight Against Prescription Drug Abuse with Safe Use Treatment Monitoring Solution
3. SuperNova Diagnostics® to Present at the Rodman & Renshaw Global Investment Conference
4. Skyline Diagnostics and Clavis Pharma to Collaborate on Patient Selection Biomarker Discovery for Leukemia Drug elacytarabine
5. Dilon Diagnostics® Partners With PenRad®
6. Chembio Diagnostics CFO Richard J. Larkin Among the Recipients of "2011 CFO of the Year" Award from Long Island Business News
7. Quest Diagnostics Declares Quarterly Cash Dividend
8. Enigma Diagnostics and GSK Announce Collaboration on Assay Development and Commercialization of Enigmas ML Platform
9. Caliper Life Sciences to Present at the Leerink Swann Life Science Tools & Diagnostics Roundtable
10. Quest Diagnostics to Unveil Extensions to its Womens Health and Personalized Medicine Test Offerings at the 2011 AACC Annual Meeting and Clinical Lab Expo
11. Ortho Clinical Diagnostics Launches VITROS® 4600 Chemistry System for Mid- to High-Volume Laboratories
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... , April 20, 2017 NeuroVive ... ("NeuroVive") today announced positive preclinical results demonstrating ... compound for non-alcoholic steatohepatitis (NASH), in an ... NV556 has previously shown similar ... model. Today, NeuroVive,s scientists present novel data ...
(Date:4/19/2017)... April 19, 2017  IRIDEX Corporation (Nasdaq: ... results for the first quarter 2017 after the close ... management team will host a corresponding conference call beginning ... Investors interested in listening to the conference call ... callers or (703) 326-3030 for international callers, using conference ...
(Date:4/19/2017)... , April 19, 2017  Sorrento Therapeutics, Inc. ... clinical-stage biopharmaceutical company developing new treatments for cancer ... closing of its previously announced underwritten public offering ... a public offering price of $2.00 per share, ... offering expenses payable by Sorrento.  The net proceeds ...
Breaking Medicine Technology:
(Date:4/24/2017)... ... 24, 2017 , ... Ridgecrest Herbals makes it a point to lead the ... waste, and support renewable energy. They believe this is a crucial part of their ... for health issues, and maintain that destroying the environment in the pursuit of profit ...
(Date:4/24/2017)... ... 2017 , ... NEPC Director Kevin Welner has been awarded ... The award honors scholars exemplary in their capacity to communicate important education research ... the capacity to deepen the public’s understanding and appreciation of the value of ...
(Date:4/24/2017)... ... April 24, 2017 , ... Today, Bright Pink , a national non-profit organization ... names a new CEO. , Bright Pink is proud to announce Katie Thiede as ... moving to a new role as Chairman of the Board and launched a national ...
(Date:4/24/2017)... Washington (PRWEB) , ... April 24, 2017 , ... Sean ... OptiGrill, Oxiclean, Space Bag, Sonicare Toothbrush, Juiceman Juicer, and the George Foreman Grill (which ... perhaps any other marketer in the last 25 years. , Now, due to changes ...
(Date:4/24/2017)... ... , ... The John P. McGovern Museum of Health and Medical Science is ... cognitive health, and share results with their physicians. Members and guests can sign up ... , BrainCheck founder, Dr. David Eagleman, formerly at Baylor College of Medicine and now ...
Breaking Medicine News(10 mins):